Enfusion Alpha and Beta Analysis
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Enfusion. It also helps investors analyze the systematic and unsystematic risks associated with investing in Enfusion over a specified time horizon. Remember, high Enfusion's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Enfusion's market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Enfusion |
Enfusion Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Enfusion market risk premium is the additional return an investor will receive from holding Enfusion long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Enfusion. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Enfusion's performance over market.| α | 0.00 | β | 0.00 |
Enfusion Fundamentals Vs Peers
Comparing Enfusion's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Enfusion's direct or indirect competition across all of the common fundamentals between Enfusion and the related equities. This way, we can detect undervalued stocks with similar characteristics as Enfusion or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Enfusion's fundamental indicators could also be used in its relative valuation, which is a method of valuing Enfusion by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Enfusion to competition |
| Fundamentals | Enfusion | Peer Average |
| Return On Equity | 0.0442 | -0.31 |
| Return On Asset | 0.0305 | -0.14 |
| Profit Margin | 0.01 % | (1.27) % |
| Operating Margin | 0.03 % | (5.51) % |
| Current Valuation | 1.01 B | 16.62 B |
| Shares Outstanding | 94.8 M | 571.82 M |
| Shares Owned By Insiders | 4.73 % | 10.09 % |
Enfusion Opportunities
Enfusion Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
About Enfusion Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Enfusion or other delisted stocks. Alpha measures the amount that position in Enfusion has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Enfusion Upcoming Company Events
As portrayed in its financial statements, the presentation of Enfusion's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Enfusion's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Enfusion's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Enfusion. Please utilize our Beneish M Score to check the likelihood of Enfusion's management manipulating its earnings.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Enfusion
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Enfusion Stock
If you are still planning to invest in Enfusion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enfusion's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |